Maxiflo 250 rotacaps

Description

Maxiflo 250 Rotacaps is an inhalation medication used for the management of asthma and chronic obstructive pulmonary disease (COPD). It contains Fluticasone Propionate (250 mcg), a corticosteroid that reduces airway inflammation, and Salmeterol Xinafoate (50 mcg), a long-acting bronchodilator that helps relax the muscles in the airways, improving airflow and easing breathing.

Key Features:
Active Ingredients:
Fluticasone Propionate (250 mcg): Reduces airway inflammation and helps prevent asthma flare-ups and COPD exacerbations.
Salmeterol Xinafoate (50 mcg): A long-acting bronchodilator that relaxes the airway muscles, ensuring better airflow.
Rotacap Format: Capsules designed for use with the Rotahaler device, ensuring accurate and effective medication delivery.
Dual Action: Provides both anti-inflammatory and bronchodilator effects for comprehensive asthma and COPD management.
30 Capsules per Pack: Ideal for long-term maintenance and treatment.

Benefits:
Improves lung function and makes breathing easier
Reduces airway inflammation and prevents bronchospasms
Helps prevent asthma attacks and exacerbations of COPD
Convenient and easy-to-use with the Rotahaler device

Specifications:
Dosage: 250 mcg Fluticasone + 50 mcg Salmeterol per rotacap
Quantity: 30 capsules
Recommended Usage: As prescribed by your healthcare provider, typically one capsule per day using the Rotahaler device.
For Use With: Rotahaler device